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Abstract
Coenzyme A (CoA) biosynthesis is regulated by the pantothenate kinases (PanK), of which there are four active isoforms.
The PanK1 isoform is selectively expressed in liver and accounted for 40% of the total PanK activity in this organ. CoA
synthesis was limited using a Pank1
2/2 knockout mouse model to determine whether the regulation of CoA levels was
critical to liver function. The elimination of PanK1 reduced hepatic CoA levels, and fasting triggered a substantial increase in
total hepatic CoA in both Pank1
2/2 and wild-type mice. The increase in hepatic CoA during fasting was blunted in the
Pank1
2/2 mouse, and resulted in reduced fatty acid oxidation as evidenced by abnormally high accumulation of long-chain
acyl-CoAs, acyl-carnitines, and triglycerides in the form of lipid droplets. The Pank1
2/2 mice became hypoglycemic during a
fast due to impaired gluconeogenesis, although ketogenesis was normal. These data illustrate the importance of PanK1 and
elevated liver CoA levels during fasting to support the metabolic transition from glucose utilization and fatty acid synthesis
to gluconeogenesis and fatty acid oxidation. The findings also suggest that PanK1 may be a suitable target for therapeutic
intervention in metabolic disorders that feature hyperglycemia and hypertriglyceridemia.
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Introduction
Coenzyme A (CoA) is an essential cofactor involved in energy
metabolism that carries carboxylic acid substrates and supports a
multitude of oxidative and synthetic metabolic reactions, including
those involved in the citric acid cycle, sterol, bile acid and fatty
acid biosynthesis, and fatty acid oxidation (for review, see [1]).
CoA is derived from vitamin B5 (pantothenate), cysteine and ATP.
Pantothenate kinase (PanK) catalyzes the first committed step and
controls the overall rate of CoA biosynthesis [1–3]. In mammals,
there are three genes that express four characterized isoforms of
PanK. PanK1a and PanK1b are encoded by the same gene and
arise from the use of alternate initiation exons [4], whereas the
PanK2 and PanK3 isoforms are encoded by distinct genes [5,6].
The PanK isoforms are feedback regulated by CoA thioesters
[4,5,7], and the loss or alteration of feedback regulation by
mutations in PanK result in dysregulated CoA production [5,8].
Thus, PanK expression levels contribute to determination of the
cellular CoA content [9,10].
The multiplicity of PanK isoforms suggests tissue-specific CoA
regulation. PanK1 transcripts are most highly expressed in liver.
PanK2 is most abundant in neuronal tissue and PanK3 is widely
and highly expressed in all tissues examined [6,10]. The
importance of CoA biosynthesis in metabolism is clearly evident
from a chemical knockout of CoA synthesis at the PanK step using
a pantothenate antimetabolite which targeted all PanK isoforms
[11]. Mice treated with the inhibitor exhibited a selective and
dramatic reduction in CoA levels in liver and kidney that resulted
in significant changes in mitochondrial morphology, defective fatty
acid oxidation, and hypoglycemia. Metabolic and gene expression
profiling revealed the critical function of unesterified CoA in
supporting gluconeogenesis and fatty acid oxidation [11].
The physiological adaptations associated with the transition
from the fed to the fasted state have been the focus of considerable
experimental interest [12]. The liver is central to the body’s
response to nutrient deprivation and switches from an organ of
glucose oxidation and fatty acid synthesis in the fed state to one of
glucose and ketone body production and fatty acid oxidation in the
fasted state [13–15]. Transcriptional regulators like PGC1a and
PPARa are activated during a fast and drive a genetic program
that alters the levels of key enzymes and regulatory factors in
intermediary metabolism, including the enzymes of fatty acid
oxidation [16]. The importance of fatty acid oxidation during
fasting to provide energy for gluconeogenesis is evident from the
study of inborn errors in mitochondrial b-oxidation and of
knockout mice with deficiencies in individual b-oxidation enzymes
[17]. CoA is a required cofactor for b-oxidation and a significant
increase in liver CoA is associated with the transition from the fed
to the fasted state [18–22]. It is not known whether elevated
intracellular CoA concentrations are as important to supporting b-
oxidation during fasting as the increased activities of fatty acid b-
oxidation enzymes.
The PanK1 isoform is highly and selectively expressed in liver,
thus we derived a Pank1
2/2 mouse model to elucidate the role of
this regulatory enzyme in the CoA response to fasting. The
PanK1-deficient liver had lower CoA, and during a fast, fatty acid
oxidation was impaired resulting in the accumulation of long-
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Gluconeogenesis in the fasted state was profoundly impaired in the
Pank1
2/2 mice, resulting in hypoglycemia. Ketogenesis was
unimpaired. These results illustrate that increasing the supply of
CoA is just as important as the expression/activity of the b-
oxidation enzymes for fatty acid metabolism during adaptation to
nutrient deprivation.
Results
Derivation and General Characteristics of the Pank1
Knockout Mice
Recombinant embryonic stem cells were obtained and mice
were generated that were heterozygous for a Pank1 gene that was
modified by insertion of loxP sites in the introns flanking exon 3
(Fig. 1A). Mating with an ACTB-Cre transgenic mouse strain
resulted in pups with a Pank1 allele in which exon 3 was deleted via
Cre recombinase-dependent excision of the DNA between the first
and third loxP sites in all tissues early in embryogenesis. The
deletion resulted also in the removal of the cDNA cassette used for
selection of the recombinant embryonic stem cells. Pank1
+/2
heterozygous mice were mated and pups with a homozygous
deletion of the Pank1 gene were obtained in the expected
Mendelian ratio as determined by tail genotyping (Fig. 1A). The
ACTB-Cre transgene was not maintained in the knockout mouse
line. The experiments were performed with 12–16 week old male
Pank1
2/2 mice.
The Pank1 knockout mice did not exhibit gross defects in
anatomy or behavior. The Pank1
2/2 mice weighed more at 10
weeks and were significantly heavier at 16 weeks compared to
the control littermates (Table 1). Serum parameters were the
same comparing the control and knockout mice with the
exception of blood glucose and triglycerides, which were lower
in the knockout mice after an overnight fast (Table 1). There was
no elevation in serum transaminases and no evidence of liver
damage or inflammation. Although PanK1 was expressed in
kidney [10], there was no indication of a defect in kidney
function from the serum and urine analysis. Neither the wild-
type nor the Pank1
2/2 knockout mice had detectable urobilin-
o g e n ,g l u c o s e ,k e t o n e s ,b i l i r ubin, or blood in the urine (not
shown). Heart is the only other tissue expressing Pank1 [10], but
real-time qRT-PCR measurements showed that heart Pank1 was
expressed at less than 2% the level of Pank1 in the liver. PanK3
was the major isoform in heart (data not shown). Thus, the
investigation of the PanK1-null phenotype focused on CoA-
mediated metabolism in liver.
Liver PanK Activity
The Pank1b transcripts accounted for 58% of the total PanK
mRNAs in wild-type liver (Table 2). Only 2% of the PanK1
isoform mRNAs were present as Pank1a, and Pank2 and Pank3
accounted for 7% and 33% of the total PanK transcripts,
respectively. The expression of the Pank2 or Pank3 genes did not
increase in the PanK1-deficient liver to compensate for loss of
Pank1 expression (Table 2). There was a 40% decrease in the total
PanK enzyme specific activity in knockout liver extracts (Fig. 1B).
This assay used unfractionated extracts and measured the sum of
all PanK isoforms. The decrease in total PanK activity in the
Pank1
2/2 extracts was consistent with the loss of Pank1 expression.
A distinguishing feature of PanK1b is that it is less sensitive to
acetyl-CoA inhibition than the other PanK isoforms [4,5,7].
Accordingly, extracts from wild-type livers possessed a fraction of
the PanK activity that was refractory to acetyl-CoA inhibition
(Fig. 1C). The acetyl-CoA-insensitive PanK activity that consti-
tuted about 40% of the total PanK activity in the wild-type liver
extract was absent from liver extracts obtained from Pank1
2/2
mice (Fig. 1C). Thus, the PanK2 and PanK3 isoforms accounted
for all of the PanK activity in the livers from Pank1
2/2 mice.
Figure 1. Generation of Pank1
2/2 mice and liver PanK activity.
(A) Diagram of the gene targeting strategy. A selection cassette
containing cDNAs encoding thymidine kinase (TK) and neomycin
resistance (NEO) was inserted into the intron between exons 2 (Ex2) and
3 (Ex3) of the Pank1 gene. The cassette was flanked by loxP (c) sites. A
third loxP site was inserted between exons 3 (Ex3) and 4 (Ex4). Cre-
recombinase-mediated deletion of the DNA between the outermost
loxP sites resulted in a knockout (KO) allele which lacked Ex3 and the
selection cassette. Locations of the primers (arrows) for PCR analysis
and genotyping are shown. PCR products and sizes are indicated (bars).
Locations of the loxP sites are indicated with triangles. A PCR product of
274 bp using primers F and R1 indicated a wild-type (WT) allele, and a
PCR product of 220 bp using primers F and R2 indicated a deleted (KO)
allele. Heterozygous (Hz) mice had both alleles. (B) Total PanK activity
(pmoles/min) was determined in liver homogenates from wild-type
(WT;N)o rPank1 knockout (KO; q) mice as a function of protein
concentration. The data are the average of duplicate measurements
obtained from 4 control and 5 knockout mice. (C) Inhibition of total
PanK activity by acetyl-CoA (AcCoA) in liver homogenates from wild-
type (WT;N)o rPank1 knockout (KO; q) mice. For WT, the 100% value
corresponds to 3363 pmoles/min/mg protein, and 1762 pmoles/min/
mg protein for KO. The data are the average of duplicate measurements
obtained with 3 mice of each genotype. Statistically significant
differences between wild-type and knockout are indicated by *
(p,0.05).
doi:10.1371/journal.pone.0011107.g001
Pank1 Knockout Mice
PLoS ONE | www.plosone.org 2 June 2010 | Volume 5 | Issue 6 | e11107Food Consumption
The higher weight noted for the Pank1
2/2 mice (Table 2) led to
a more comprehensive study. Weight monitoring clearly showed
the Pank1
2/2 mice gained more weight as they aged compared to
their littermate controls (Fig. 2A). A food monitoring study
revealed that the Pank1
2/2 mice ate significantly more food than
the controls, and retained the same percentage of the fat calories as
the control animals (Fig. 2B). These data revealed that hyperphagy
accounted for the greater weight gain of the Pank1
2/2 mice. CoA
metabolism in the hypothalamus has been implicated in the
regulation of feeding behavior [23], and so we determined the
relative distribution of the PanK isoforms in wild-type hypothal-
ami. The Pank1 transcripts constituted 6.2% (n=3 mice) of the
PanK isoforms, and thus a perturbation of CoA metabolism may
underly the increased food consumption.
Reduced CoA Levels and Fatty Acid Oxidation
We measured hepatic CoA levels during fasting and compared
mice fed regular chow ad libitum and mice fasted for 24 or 48 h
(Fig. 3). These data show that the free CoA pool is the largest CoA
species in mammalian cells, in agreement with our previous
measurements [11]. Note the difference in scale between the free
CoA measurements compared to the short-chain and long-chain
acyl-CoAs. There was a significant increase in the free and short-
chain acyl CoA content following fasting of the wild-type animals
that reached the highest levels at 48 h (p,0.05) (Fig. 3A and 3B).
In contrast, the PanK1-deficient livers had lower free CoA than
wild-type livers under both fed and fasted conditions (p,0.05),
and the free CoA did not increase during fasting in the knockouts
(Fig. 3A). Meanwhile, short-chain acyl-CoA levels increased
modestly in the knockout animals during a 48 h fast. Although
the data indicated a lower short-chain acyl-CoA trend in the
knockouts, the levels were not significantly different from those of
the wild-type animals (Fig. 3B). The overall increase in CoA
content during fasting was not driven by increases in the transcript
levels of the PanK genes (Table 2). In wild-type animals, none of
the PanK genes exhibited increased expression during fasting, and
the elimination of PanK1 expression did not increase the
transcript levels for Pank2 or Pank3 following fasting. In fact, there
was a decrease in the level of Pank2 and Pank3 mRNAs in the
fasted, knockout animals. On the other hand, the expression of
mouse nudix hydrolase 7 (Nudt7), a liver-specific CoA-phospho-
diesterase [24], was downregulated during fasting in both wild-
type and knockout livers (Table 2), in agreement with previous
results [25,26]. The Nudt19 CoA phosphodiesterase [27] was also
expressed, but the contribution of the Nudt19 isozyme was
quantitatively 10-fold less than Nudt7, based on the transcript
levels after fasting. These data were consistent with decreased CoA
degradation during the fasting response, thus contributing to the
increase in free CoA in the wild-type livers and the increased
short-chain acyl-CoAs in both control and PanK1-deficient livers
(Fig. 3A).
A significant difference between wild-type and knockout
animals was the marked increase in long-chain acyl-CoAs in the
Pank1
2/2 livers after a 48 h fast (Fig 3C). While the long-chain
acyl-CoA levels in wild-type livers increased during fasting, as
Table 1. General features of the Pank1
2/2 mice.
Parameter Mouse Genotype
Wild-Type Pank1
2/2
Weight, g, 10 weeks 24.760.6 (11) 26.760.7 (16)
Weight, g, 16 weeks 27.060.8 (11) 30.260.9 (15)*
Glucose, mg/dL 7462 (24) 5562 (26)*
Cholesterol, mg/dL 12169 (6) 111613 (6)
Triglycerides, mg/dL 16069 (8) 11369( 7 ) *
Free Fatty Acids, mM 1.360.1 (5) 1.260.2 (5)
AST
a, U/L 172639 (6) 181639 (6)
ALT
b,U / L 8 1 625 (6) 76617 (6)
Ketones (fed), mM 0.2360.02 (9) 0.2860.05 (9)
Ketones (48h fast), mM 1.860.32 (13) 2.560.56 (11)
Animals were fasted overnight (14 h) prior to the serum measurements. Values
are reported as the mean 6 standard error (number of mice).
aAspartate aminotransferase.
bAlanine aminotransferase.
*p,0.05.
doi:10.1371/journal.pone.0011107.t001
Table 2. Effect of fasting on the mRNA of the PanK and CoA diphosphatase (nudix hydrolase) isoforms in the livers of wild-type
and Pank1
2/2 mice.
Relative Pank and Nudt isoform mRNA abundance in liver
Gene Fed 24 h Fasted 48 h Fasted
Wild-Type Pank1
2/2 Wild-Type Pank1
2/2 Wild-Type Pank1
2/2
Pank1a 0.2560.09 (5) ND (5) 0.2660.08 (4) ND
a(5) 0.3560.17 (9) ND (7)
Pank1b 10.0062.13 (5) ND (5) 12.6262.42 (5) ND (5) 13.7665.80 (9) ND (7)
Pank2 0.9560.18 (5) 0.8360.20 (5) 0.8460.09 (5) 0.7960.17 (5) 1.0860.24 (9) 0.4060.12
c(7)
Pank3 5.4161.15 (5) 5.9461.51 (5) 5.0661.21 (5) 5.4761.10 (5) 6.0361.29 (9) 3.261.42
c(7)
Nudt7 2.1160.62 (5) 2.7760.75 (7) NA
b NA 0.7760.34
d(7) 0.6360.39
d(7)
Nudt19 0.01660.003 (5) 0.03360.018 (7) NA NA 0.07960.034
d(7) 0.05160.017 (7)
The PanK1b transcript was the most abundant PanK mRNA in the wild type liver, and its level was set at 10. The abundance of all other PanK isoforms was expressed
relative to PanK1b. The mRNA abundance of nudix hydrolases is reported relative to a cyclophilin calibrator. Each transcript was measured in triplicate for each mouse
sample, and the combined results are shown, 6 s.d. (number of mice).
aND means not detectable.
bNA means not analyzed.
cMeans statistically significant difference between Pank1
2/2 and controls (p,0.05).
dMeans statistically significant difference between fed and fasted (p,0.05).
doi:10.1371/journal.pone.0011107.t002
Pank1 Knockout Mice
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These data pointed to a defect in long-chain acyl-CoA
metabolism. Fifteen minute measurements of the rates of fatty
acid oxidation demonstrated reduced capacity for oxidation in the
fasted Pank1
2/2 livers compared to fasted wild-type livers (Fig. 3D).
The fatty acid oxidation capacity increased substantially in the
wild-type livers after a 48h fast, but the capacity of the knockout
livers remained the same as in the fed state. The oxidation
measurements were made without the addition of CoA, and thus
reflected the endogenous free CoA as well as the changes in gene
expression engendered by fasting, largely mediated by activation
of PPARa. Thus, the increase in long-chain acyl-CoAs (Fig. 3C)
was consistent with the decreased capacity for acyl-CoA oxidation
during fasting when the animals became more reliant on mobilized
fatty acids as an energy source.
Analysis of the liver lipid composition corroborated this view
(Fig. 4A). In control mice, liver triglyceride levels increased slightly
after a 24 h fast and then returned to the fed level at 48 h. In
contrast, the PanK1-deficient livers actually had lower levels of
triglycerides than the control mice in the fed state, and the
triglycerides also increased after a 24 h fast. The amount of
hepatic triglyceride was variable at 24 h, with some Pank1
2/2
animals having levels similar to wild-type while others had
significantly elevated triglycerides, giving rise to a large spread in
the values at this time point. However, by 48 h, the triglyceride
content of the CoA-deficient livers was consistently 5 times higher
than in the wild-type controls (Fig. 4A). The storage of excess fatty
acid as triglyceride in the knockout livers illustrated that the
amount of free CoA became limiting to fatty acid oxidation in the
physiologic context of the fasted state, when there is increased fatty
acid mobilization and an upregulation of fatty acid degradative
gene expression mediated by PPARa activation.
Histology of the Pank1-Deficient Liver
Histological examination of liver sections did not reveal any
marked differences between the control and Pank1
2/2 mice in the
fed state (Fig. 4B). Following a 48 h fast, numerous cellular
inclusions were noted in the PanK1-deficient livers, and staining
with oil red O clearly showed the accumulation of neutral lipid
droplets (Fig. 4B). This finding was corroborated by electron
microscopy (Fig. 4C). Occasional lipid droplets were observed in
the wild-type fed livers and similarly after a 48 h fast. In contrast,
lipid droplets were rare in the fed CoA-deficient livers and the
hepatocytes became replete with lipid droplets after a 48 h fast.
These data were in agreement with the triglyceride measurements
(Fig. 4A), and supported a defect in the catabolism of fatty acids in
the fasted CoA-deficient livers.
Accumulation of Long-chain Acyl-Carnitines
The acyl-carnitine levels in the wild-type and CoA-deficient
livers were determined in the fed state and following a 48 h fast for
two reasons. First, long-chain acyl-carnitines are activators of
PanK2 [7] and PanK3 (Leonardi and Jackowski, unpublished
data). Allosteric activation of these PanKs by acyl-carnitine could
contribute to the increase in CoA levels in the fasted liver. Second,
acyl-carnitine levels are an indicator of the efficiency of fatty acid
oxidation and accumulate in cells and body fluids when fatty acid
oxidation is impaired [28,29]. Free carnitine was the most
abundant intracellular species and increased substantially follow-
ing fasting and to the same extent in both control and PanK1-
deficient livers (Fig. 5A). Carnitine synthesis and uptake are both
stimulated by activation of PPARa [30] and these measurements
reflect a normal fasting response in both control and knockout
animals. Acetyl-carnitine was significantly higher in the CoA-
deficient livers in both the fed and fasted states (Fig. 5B). The
transfer of acetyl moieties between carnitine and CoA occurs in
mitochondria and reflected the CoA deficiency and the impor-
tance of liberating nonesterified CoA to support fatty acid
degradation [11]. There were only minor differences in the 3-
and 4-carbon acyl-carnitines (Fig. 5C). A striking accumulation of
.C10 acyl-carnitines in the PanK1-deficient livers was evident in
both the fed and fasted states, suggesting that activation of PanK2
and/or PanK3 may contribute to supporting tissue CoA levels in
the absence of PanK1 (Fig. 5D and 5E). The amounts of C16:0,
C18:0 and C18:1 acyl-carnitines increased significantly following a
48 h fast, reflecting the reduced capacity for fatty acid oxidation in
Figure 2. Weight monitoring and food intake in Pank1 knockout
mice. (A) Body weight as a function of age was measured in 11 wild-
type (WT) and 16 knockout (KO) mice. (B) Food intake: food
consumption was monitored in 16 wild-type (WT) and 11 knockout
(KO) mice. Fat retained: the percentage of fat retained by 4 wild-type
(WT) and 8 knockout (KO) mice. 100% corresponds to 200 mg of lipids
retained/mouse/24 hours for WT, and 276 mg of lipids retained/mouse/
24 hours for KO. These data were calculated from the measured
amount of lipid ingested minus the measured amount of lipid excreted
in the feces. Statistically significant differences between wild-type and
knockout are indicated by * (p,0.05).
doi:10.1371/journal.pone.0011107.g002
Pank1 Knockout Mice
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carnitines were lower in the wild-type livers and the distribution
did not change significantly after fasting, indicating that long-chain
acyl-carnitine activation of PanK2/3 did not contribute to the
increased CoA during fasting in the wild-type liver. These
metabolomic measurements supported the conclusion that there
was impaired fatty acid degradation in the CoA-deficient
hepatocytes.
Fatty acid oxidation occurs in mitochondria and peroxisomes,
which sequester a substantial fraction of total cellular CoA [1].
Mitochondria have an active CoA transport mechanism [31,32]
and achieve millimolar concentrations within the matrix [33,34].
CoA plays a major role as an acyl group carrier in these pathways
and the availability of unesterified CoA is critical to the operation
of fatty acid oxidation, tricarboxylic acid metabolism and the urea
cycle [11]. The lower levels of total CoA in the Pank1
2/2 liver
suggested there was either a reduced amount of CoA per
mitochondrion or fewer mitochondria in the Pank1
2/2 mice. A
quantitative measurement of the nuclear to mitochondrial DNA
copy number was performed to determine if there was a difference
Figure 3. CoA levels and fatty acid oxidation in the PanK1-deficient liver. (A) Levels of free CoA were measured in livers from 4 wild-type
(WT) and 4 Pank1 knockout (KO) mice and reported as a function of tissue wet weight. The mice were fed ad libitum, or fasted for either 24 or 48 h.
The data are the averages of duplicate measurements on each mouse of each genotype 6 standard error. (B) Levels of short-chain acyl-CoA were
measured in livers from wild-type (WT) and Pank1 knockout (KO) mice and reported as a function of tissue wet weight. The acyl chain lengths include
C2 through C12, inclusive. The mice were fed ad libitum, or fasted for either 24 or 48 h. The data are the averages from duplicate measurements from
4 control and 4 knockout mice 6 standard error. (C) Levels of long-chain acyl-CoA were measured in livers from wild-type (WT) and Pank1 knockout
(KO) mice and reported as a function of tissue wet weight. The acid-insoluble long-chain acyl-CoAs include C14:0 and longer [75]. The data are the
averages from duplicate measurements from 4 control and 4 knockout mice 6 standard error. (D) Rates of fatty acid oxidation were measured in liver
extracts derived from 4 fed wild-type (WT) or 5 fed knockout (KO) mice. Rates of fatty acid oxidation were measured in liver extracts derived from 4
wild-type (WT) or 5 knockout (KO) mice fasted for 48 h. 100% corresponds to 7.7 pmoles of
3H-palmitic acid oxidized/min/mg protein. The data are
the averages of duplicate measurements from control and knockout mice 6 standard error. Statistically significant differences between wild-type and
knockout are indicated by * (p,0.05).
doi:10.1371/journal.pone.0011107.g003
Pank1 Knockout Mice
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response. We did not find a significant difference in the number of
mitochondria in the control or CoA-deficient livers, fed or fasted
(Fig. 6A). These data indicated that the intracellular CoA
concentration did not impact mitochondrial biogenesis, but rather
a deficiency in the amount of CoA per mitochondrion contributed
to the global reduction in fatty acid oxidation in the fasted livers of
the knockout mice.
Figure 4. Development of a fatty liver in fasted Pank1
2/2 mice. (A) TG levels in 4 wild-type (WT) and 4 PanK1 knockout (KO) mouse livers were
determined in the fed state and following a 24 or 48 h fast. Statistically significant differences between wild-type and knockout values are indicated
by * (p,0.05). (B) Histology of wild-type (WT) and PanK1 knockout (KO) liver in the fed state and following a 24 or 48 h fast. Liver tissue was stained
with either hemotoxylin-eosin (H&E) or oil red O (ORO). (C) Transmission electron microscopy of hepatocytes from fed and 48-h fasted wild-type (WT)
and Pank1 knockout (KO) mice. N, nucleus; G, glycogen, and L, lipid droplets. Statistically significant differences between wild-type and knockout
samples are indicated by * (p,0.05).
doi:10.1371/journal.pone.0011107.g004
Pank1 Knockout Mice
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induction of gluconeogenesis. The levels of this factor were elevated
10–12 fold and there was no difference between the control and
Pank1
2/2 livers (Fig. 6B). Also, the elevations in phosphoenoylpyr-
uvate carboxykinase (4–10 fold) and glucose-6-phosphatase (3–8
fold) mRNAs that are normally associated with fasting occurred in
control and Pank1
2/2 livers (Fig. 6B). These data illustrate that the
genetic program that switches the liver to gluconeogenesis during
fasting was intact in the CoA-deficient livers.
Glucose Homeostasis in Pank1
2/2 Mice
Analyses of 14-hour fasted serum glucose levels indicated that
the Pank1
2/2 mice had lower serum glucose than the wild-type
controls (Table 1). Therefore, we examined glucose levels as a
function of time after initiating a fast (Fig. 6C). The control mice
responded with depressed blood glucose during the fast (Fig. 6C).
The Pank1
2/2 mice had significantly lower blood glucose levels at
each time point.
Despite a normal induction of the gluconeogenic genes (Fig. 6B),
the data suggested that the Pank1
2/2 mice became progressively
more compromised in gluconeogenesis as the fast progressed. A
direct test of this idea was a pyruvate challenge experiment that
measured blood glucose in response to the administration
of pyruvate, a major gluconeogenic substrate (Fig. 6D). The
Pank1
2/2 mice were severely compromised in the pyruvate
challenge. We reasoned that pyruvate carboxylase, the first step
in the gluconeogenic pathway from pyruvate, may have been
affected by CoA depletion because it is a mitochondrial enzyme
that absolutely requires acetyl-CoA as a cofactor [35]. This idea
was tested with an oxaloacetate challenge and a glycerol challenge
(Fig. 6E). Oxaloacetate and glycerol are cytosolic gluconeogenic
intermediates that enter the pathway downstream of pyruvate
carboxylase. Gluconeogenesis from these substrates would be
independent of pyruvate carboxylase activity. Furthermore,
oxaloacetate is converted to glucose as efficiently as pyruvate in
liver perfusion experiments [36]. However, the Pank1
2/2 mice
were severely compromised in their response to oxaloacetate or
glycerol (Fig. 6E and 6F), suggesting a deficit in NADH and/or
ATP, two products provided by fatty acid oxidation during fasting.
On the other hand, the knockout animals were competent in
ketogenesis and had higher levels of serum ketones after a 48 h fast
that was equivalent to the levels in the wild-type animals (Table 1).
Although ketone bodies are produced in mitochondria from
acetyl-CoA derived from fatty acid oxidation, their production
does not require ATP or NADH, two important products of fatty
acid oxidation. Formation of ketones also results in the liberation
of two CoA molecules. Thus, ketone body formation continued to
supply an energy source to the serum and also recycled
intracellular CoA, rendering the fast tolerable in the knockout
animals. The acetyl-CoA for ketone body formation was provided
by the limited fatty acid oxidation in the knockout livers.
Discussion
Our results demonstrate that PanK1 expression is necessary to
maintaina normalintracellularlevel ofCoAand to fully support the
metabolic changes during the transition from the fed to the fasted
state. The Pank1
2/2 mice are unable to fully adapt to the metabolic
stress of fasting. The CoA-deficient livers have attenuated rates of
fatty acid oxidation that are associated with abnormally high
accumulation of long-chain acyl-CoAs and acyl-carnitines, and the
development of microvesicular steatosis. An approximately 25%
deficiency in fatty acid oxidation in the fasted state correlates with
accumulation of liver triglyceride over a 48-hour period and a
significant impairment of gluconeogenesis from pyruvate, oxaloac-
etate or glycerol. A marked hypoglycemia results after a 48 h fast of
the knockout animals, whereas the serum ketone levels are the same
in wild-type and knockout animals following a fast. These data
illustrate that ketone body formation is not as dependent on the
intracellular CoA level as gluconeogenesis. Unlike glucose forma-
tion, ketone synthesis does not require ATP or NADH, both of
which are supplied by fatty acid oxidation. The supply of reducing
equivalents to the cytosol is one of the key functions of fatty acid
oxidation in support of gluconeogenesis [37]. The continued
production of ketones renders the fast tolerable, i.e., the animals
do not become lethargic or succumb to coma, even when the fast is
extended to 72 hours (data not shown).
Figure 5. Elevated long-chain acyl-carnitines in the fasted
Pank1 knockout liver. Acyl-carnitines were extracted from the livers
of 3 wild-type (WT) and 3 Pank1 knockout (KO) mice that were fasted for
48 h and each liver was extracted and quantified by mass spectrometry
as described in ‘‘Experimental Procedures.’’ (A) Free carnitine levels. (B)
Acetyl-carnitine levels. (C) Propanoyl- and butanoyl-carnitine levels. (D)
Medium-chain acyl-carnitine levels. (E) Long-chain acyl-carnitine levels.
Statistically significant differences between wild-type and knockout
values are indicated by * (p,0.05).
doi:10.1371/journal.pone.0011107.g005
Pank1 Knockout Mice
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toward ketogenesis or the TCA cycle, and thus all three of these
metabolic processes are linked together. The TCA cycle becomes
restricted during fasting, however, due to the increase in NADH
which inhibits isocitrate dehydrogenase. The oxaloacetate from
the TCA cycle is then diverted to gluconeogenesis, thereby sparing
acetyl-CoA for ketogenesis [38,39]. Ketogenesis has the added
benefit of releasing two molecules of unesterified (free) CoA for
each ketone formed, which can be recycled for additional acetyl-
CoA formation from fatty acids in the CoA-deficient liver.
Complete oxidation of a 16:0 fatty acid requires the input of 8
free CoA molecules to produce 8 acetyl-CoAs. In contrast, the
TCA cycle utilizes 1 acetyl-CoA which is recycled to succinyl-CoA
and then released as 1 free CoA during a complete turn of the
cycle. Ketogenesis uses 2 acetyl-CoAs and releases 2 free CoAs.
The free CoApool is the largest pool in mammalian cells and it is
the free CoA pool that is most reduced in the Pank1 knockout
animals (Fig. 3A).
The phenotype of the PanK1-deficient mouse is reminiscent of
humans and animals with mutations in the enzymes of fatty acid
oxidation that utilize CoA [17,40,41]. The most severely affected
are those patients with deficiencies in long-chain acyl-CoA
dehydrogenase that catalyzes the first step in the mitochondrial
pathway. These subjects exhibit hypoketosis and hypoglycemia
during a fast, whereas only fasting hypoglycemia arises from
partial defects in b–oxidation [40,42,43]. Animals with deficiencies
in acyl CoA oxidase [44] or short-chain acyl CoA dehydrogenase
[45] exhibit spontaneous steatosis, but animals with deficiencies in
very long chain acyl CoA dehydrogenase [46], long chain acyl
CoA dehydrogenase [42], medium chain acyl CoA dehydrogenase
[47], dienoyl CoA reductase [43], enoyl-CoA isomerase [48] and
PPARa [49] exhibit steatosis only upon fasting. Our mice most
closely resemble the mitochondrial 2,4-dienoyl-CoA reductase
deficient mice [43]. These animals oxidize saturated fatty acids
normally, but can only partially degrade unsaturated fatty acids.
Like the Pank1
2/2 mice, this partial fatty acid oxidation defect
gives rise to fasting steatosis and hypoglycemia with normal
ketogenesis [43]. Thus, increasing the intracellular level of CoA is
as critical to the normal fasting response as the PPARa-mediated
up-regulation of the fatty acid oxidation pathway.
A curious aspect of the Pank1
2/2 phenotype is the lower
triglyceride level in the fed state compared to wild-type animals
(Fig. 4), coupled with lower serum triglyceride levels (Table 1). The
lower triglyceride accumulation in liver could be due to altered
fatty acid uptake, altered fatty acid synthesis or lower triglyceride
synthesis, all of which are CoA-dependent processes. Acetylation
of the proteins of intermediary metabolism, in particular the enoyl-
CoA hydratase/3-hydroxyacyl-CoA dehydrogenase of fatty acid
Figure 6. Liver mitochondrial number and global glucose homeostasis in the Pank1 knockout mice. (A) The number of mitochondria per
cell was estimated using quantitative real-time PCR to measure the ratio of mitochondrial to nuclear DNA in livers from 4 wild-type (WT) and 5 Pank1
knockout (KO) mice each in the fed state and after a 48 h fast. (B) qRT-PCR quantification of PGC1a, phosphoenoylpyruvate carboxykinase (PEPCK)
and glucose-6-phosphatase (G6Pase) mRNA in the livers of fed or fasted wild-type (WT; n=5) and Pank1 knockout (KO; n=5) mice. (C) Serum glucose
levels wild-type (WT; n=9) and Pank1 knockout (KO; n=10) mice during fasting. (D) Gluconeogenesis in 4 wild-type (WT) and 4 Pank1 knockout (KO)
mice measured with a pyruvate challenge test. (E) Gluconeogenesis in 6 wild-type (WT) and 6 Pank1 knockout (KO) mice measured with an
oxaloacetate challenge test. (F) Gluconeogenesis in 9 wild-type (WT) and 10 Pank1 knockout (KO) mice measured with a glycerol challenge test *,
p,0.05.
doi:10.1371/journal.pone.0011107.g006
Pank1 Knockout Mice
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also be impacted by lower CoA in the knockout animals, in the fed
as well as the fasted state. These regulatory implications are under
investigation.
The Pank1
2/2 mice recapitulate the abnormal fasting metab-
olism observed in pantothenate-deficient animals. Fasted rats on a
pantothenate-deficient diet are hypoglycemic compared to either
ad libitum or pair fed controls [51,52]. Fasted pantothenate-
deficient rats are also impaired in gluconeogenesis [53], while
ketogenesis is not affected [54]. Two other consistently document-
ed symptoms in pantothenate-deficient animals are weight loss and
neurological problems manifested as spasticity/dragging of the
hind limbs or abnormal gait [51,52,54–56]. Abnormal gait is also
observed in pantothenate-deprived humans [57], and are
reminiscent of PKAN disease arising from mutations in PANK2
[58]. However, neither of these symptoms are observed in the
Pank1
2/2 mice in this study or in the Pank2
2/2 mouse model [59].
Thus, the PanK1-deficient mouse exhibits only the metabolic
defects associated with global pantothenate deficiency. This
conclusion is consistent with the importance of the liver in energy
homeostasis during nutrient deprivation and the high PanK1
expression in this organ.
Mitochondrial CoA levels would primarily be affected by lack of
PanK1. The rate-limiting enzymes for gluconeogenesis, ketone
body formation, fatty acid oxidation and the tricarboxylic acid
cycle are all in the mitochondria. It is known that most of the CoA
in the cell is in the mitochondria, but CoA biosynthesis occurs in
the cytosol. Mitochondria actively import CoA [32] and the CoA
concentration in mitochondria is about 100-fold higher than the
cytosol [1]. Previously published data show that the ratio of
mitochondrial CoA to total CoA is maintained during fasting
[20,60]. Because there is lower total CoA and about the same
number of mitochondria (Fig. 3 and 6), we conclude that there is
less CoA per mitochondrium in the knockout livers.
Another important discovery in this study is that the regulation
of CoA levels during fasting is mediated by factors other than
PanK gene expression. The mRNA levels for the PanK isoforms
did not increase during fasting. The intracellular activities of
PanK2 and PanK3 could be increased by allosteric regulators such
as long chain acyl-carnitines [7]; however, the small increase in
acyl-carnitine levels in the fasted wild-type animals suggests that
this mechanism is not the underlying cause in normal animals. On
the other hand, there was substantial elevation in long-chain acyl-
carnitines in the CoA-deficient livers, suggesting that stimulation
of PanK2 and PanK3 activities may compensate in part for the
loss of PanK1. This adaptive mechanism may contribute to the
modest increase in CoA in the fasted Pank1
2/2 animals, as the
levels of C16:0, C18:0 and C18:1 acyl-carnitines are significantly
elevated. Previous work shows that CoA degradation is substantial
in the liver, but not in other tissues [11]. Nudix hydrolases are
responsible for CoA degradation. The Nudt7 phosphodiesterase is
selectively expressed in liver [24], and the increase in fasting CoA
levels correlates with the downregulation of Nudt7 expression
[25,26] (Table 2). Fasting regulation of Nudt7 activity occurs at
the level of transcription, and Nudt7 mRNA is strongly
downregulated by Wy-14,643, a PPARa agonist [26]. These
correlations suggest that Nudt7 has a central role in CoA
homeostasis.
The marked effects on fatty acid oxidation due to lower CoA
levels may provide some insight into understanding the neurolog-
ical defects in PKAN disease. PanK1 is expressed at low levels in
the brain, which primarily expresses PanK2 and PanK3 [61].
PKAN arises from mutations in the human PANK2 gene [6],
which is localized to the mitochondria in humans [62]. It is not
known whether the inactivation of PanK2 results in decreased
cellular CoA in human neurons, but the significant effects of
PanK1 inactivation in the liver suggest that the elimination of
PanK2, a substantial isoform in brain, would have similar
consequences for neuronal CoA homeostasis. This reasoning
suggests that PanK2 deficiency would also compromise fatty acid
metabolism in the brain due to compromised oxidation. This idea
suggests that PKAN disease, like Parkinson’s [63] and Alzheimer’s
[64] neurodegenerative diseases, involves defects in mitochondrial
function.
Materials and Methods
Ethics Statement
All procedures were performed according to protocol 323 which
was approved by the St. Jude Children’s Research Hospital
Institutional Animal Care and Use Committee.
Generation of Pank1
2/2 Mice
The targeting construct (pPJ288) was generated by cloning 3
fragments of mouse Pank1 genomic DNA into vector pNEOtk-
LoxP. Plasmid pPJ288 contained a loxP site between a 2.2-kb
genomic DNA and the TK and NEO selection cassettes, followed
by a second loxP site upstream of a 2-kb genomic DNA fragment
containing exon 3, and by a third one upstream of a 3.9-kb
genomic DNA (Fig. 1A). The targeting vector was digested with
DraIII restriction enzyme prior to transfection into the mouse
embryonic stem cell line derived from strain 129/SvEv (Specialty
Media), grown on mitotically inactivated mouse embryonic
fibroblasts which were resistant to neomycin. Clones resistant to
the neomycin analog G418 were selected and screened by PCR
using Expand Long Template PCR System (Roche) and two
primers: RecF (59-GGCATAGGCTCCTGAGGC) and T (59-
GGTCCACGACCCAAGCTG). ES cells that had undergone
homologous recombination with the targeting construct were
identified by a 2456 bp product. The presence of the third loxP
site was confirmed by performing PCR with primers Ex3F (59-
GGTCTGAGTGCATTTCTTGTC) and R2 (59-GCCTAAT-
TTCGTTCACAGTGG) and then digesting the PCR product
with BamHI. The wild type allele yielded a product of 1218 bp;
the allele with the loxP site yielded two bands of 1072 and 128 bp.
Embryonic stem cells containing the recombined Pank1 DNA at
the correct locus were injected into C57BL6/J mouse blastocysts,
which were then implanted into pseudopregnant female mice by
the St. Jude Transgenic Core Facility. Male chimeric offspring
with 75 to 90% agouti color, the coat color contributed by the
embryonic stem cells, were bred with C57BL6/J females. Pups
that were 100% agouti, indicating germ line transmission, were
screened. Tail clips were lysed and multiplex PCR analysis was
used to genotype the mice using RED Extract-N-Amp PCR kit
(Sigma) and three primers: F (59-GGATAGGATGGCTAC-
TAGCTGC), R1 (59-TTACTAGCTAAGTGGCCCAGG) and
T (see above). The wild type allele yielded a product of 274 bp,
and the recombinant floxed Pank1 allele yielded a product of
148 bp. FVB/N-Tg(ACTB-cre)2Mrt/J mice expressing Cre
recombinase under the human b-actin gene promoter were
utilized to generate a deletion within the floxed Pank1 gene by
recombination of the first and third loxP sites, resulting in the loss
of exon 3. A multiplex PCR analysis was used to genotype the
offspring from the breeding of ACTB-cre mice with mice
heterozygous for the floxed Pank1 using primers F, R1 and R2.
A 274-bp product indicated the presence of a wild type allele, and
a 220 bp product indicated the presence of a knockout allele. The
percentage of C57Bl6 background of the Pank1 KO and WT mice
Pank1 Knockout Mice
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analysis conducted by Jackson Laboratories. The control mice for
the experiment were age matched siblings with the same
percentage of C57Bl6 genotype.
Animal Studies
Unless otherwise stated, 12–16 week-old mice were used for all
the experiments. Mice were maintained at a room temperature of
7262uF, room humidity of 50%610%, and a 14 hr light, 10 hr
dark cycle, with the dark cycle starting at 20:00 hr. For
experiments that required fasting, mice were transferred to clean
cages containing floor grids and food was removed for the
indicated time. The use of floor grids prevented coprophagia
during fasting, and reduced the incidence of unusually high
glucose levels in mice after a 48 h fast. Water was supplied ad
libitum. Glucose levels were measured via tail bleeding using a
glucometer (FreeStyle). For the pyruvate, oxaloacetate and
glycerol challenges, 4–10 mice per genotype were fasted overnight
and then injected intraperitoneally with 2 g/kg of pyruvate or
glycerol and 1 g/kg of oxaloacetate (pH=7.0) in a volume of
10 ml/kg. Glucose was measured before injection of the
compounds (t=0) and after 15, 30, 45, 60, 90 and 180 min.
Blood was drawn either by retro-orbital bleeding or by cardiac
puncture for triglyceride, free fatty acid and ketone body
measurements. Serum triglycerides were analyzed by the Veter-
inary Pathology Core at St. Jude Children’s Research Hospital.
Free fatty acids and ketone bodies were determined using the
BioVision Fatty Acid Assay Kit and the Stanbio Laboratory b-
Hydroxybutyrate Liquicolor kit, respectively, following the
manufacturers’ instructions. Male mice were used for all
procedures which were performed according to protocol 323
approved by the St. Jude Children’s Research Hospital Institu-
tional Animal Care and Use Committee.
Food Monitoring
The mice were fed a regular rodent diet (LabDiet 5013). To
determine food intake, mice had unrestricted access to a pre-
weighed amount of food, and residual chow was measured every
48 h for 6 days. Food intake was calculated as the difference
between food provided and left over, the data were averaged and
reported as amount of food eaten per 24 h per mouse. To analyze
the lipid balance (lipid intake and output), the lipid content of the
feces produced in 24 h was determined gravimetrically in triplicate
as described by Argmann et al. [65], and subtracted from the total
lipids present in the amount of food ingested over 24 h. The results
were averaged and reported as % of retained lipids.
Determination of PanK Expression, PanK Activity and CoA
Levels
Mice were euthanized and the livers were quickly excised and
either immersed in RNAlater (Ambion) or flash frozen in liquid
nitrogen. The PanK isoform expression in knockout and control
livers of fed or fasted animals was determined by real time qRT-
PCR using the primers and probes previously reported [61].
Primers for PGC1a, PEPCK, G6Pase, Nudt7 and Nudt19 are
listed in Table 3. To determine the PanK activity, ,200 mg of
frozen tissue was homogenized in cold buffer (1 ml, 20 mM
K2HPO4, 1 mM ATP, pH 7.4) using a Dounce tissue grinder.
The homogenates were centrifuged at 20,0006g, 4uC for 45 min,
and the supernatants were dialyzed overnight in the homogeni-
zation buffer. The protein concentration of the dialyzed samples
was determined [66] and adjusted to 20 mg/ml in 20 mM
K2HPO4, pH 7.4. PanK activity was assayed in reaction mixtures
containing 100 mM Tris-HCl, pH 7.4, 10 mM MgCl2, 2.5 mM
ATP, 90 mM D-[1-
14C]pantothenate (specific activity, 27.5 mCi/
mmol), 0–200 mg of homogenate protein. Samples were incubated
at 37uC for 30 min, after which time the reactions were stopped
and analyzed as previously described [4]. The inhibitory effect of
acetyl-CoA on the liver PanK activity was determined by
including increasing concentrations of the compound in the
reaction mixtures, as indicated. The free CoA and CoA thioester
levels were determined as previously described [61].
Determination of Mitochondrial Number
Mice (4–5 per genotype) were sacrificed in the fed state or
following a 48h fast for mitochondrial DNA quantitation. The
livers were quickly removed, snap frozen in liquid nitrogen and
stored at 280uC until used. Genomic DNA was extracted from
these samples using the protocol described by Strauss [67].
Relative mitochondrial copy number to nuclear copy number was
determined by RT-PCR as described by Stites et al. [68] using
150 ng of DNA for nuclear DNA quantitation and 400 pg for
mitochondrial DNA quantitation. Each sample was analyzed in
quadruplicate.
Lipid Analysis
Lipids were extracted from ,50 mg of liver using a modification
of the Bligh and Dyer procedure [69] optimized for lipid
quantitation by the LipidMaps group [70]. The amount of each
major lipid class was estimated by flame-ionization thin layer
chromatography using an Iatroscan MK-5 (Iatron, Tokyo, Japan).
Triglycerides, cholesterol and cholesterol esters were separated
using hexane:ether (90/10, v/v). Phospholipids were resolved using
chloroform:methanol:acetic acid:water (50/25/8/2, v/v/v/v). The
lipids were identified by co-migration with authentic standards and
quantified by comparison with known amounts of these standard
lipids.
Histology and Electron Microscopy
Hematoxylin and eosin (H&E) and Oil Red O (ORO) staining
of liver sections was performed by the Veterinary Pathology Core
at St. Jude Children’s Research Hospital. Analysis by Transmis-
sion Electon Microscopy was performed by the Cell and Tissue
Imaging Core at St. Jude Children’s Research Hospital. For H&E
staining, the livers were fixed in 10% formalin. ORO staining was
performed on frozen sections embedded in Shandon Cryomatrix
(Thermo Scientific). Animals were perfused with EM grade 4%
paraformaldehyde (Electron Microscopy Sciences) [71], the liver
excised and stored in 2.5% glutaraldehyde in 0.1 M sodium
cacodylate buffer at 4uC for 24h before processing. The tissue was
then rinsed in the same buffer 3 times and dehydrated in a graded
series of alcohol and then propylene oxide. The tissue was
infiltrated and embedded in epon araldite and polymerized
Table 3. List of primers used for quantitative real time PCR.
Gene Forward Primer (59R39) Reverse Primer (59R39)
Nudt7 CCAAGTGGAGGTGGTCTCTC GATGAAATCACGGCCAGACT
Nudt19 ATCTGTGCCATCCGCGAAGC CACAGCTGGAGGAAGCAGCG
Ppargc1a TAGGCCCAGGTACGACAGC GCTCTTTGCGGTATTCATCC
Pck1 GCTGGCAGCATGGGGTGTTT TTGGGCAACTTGGCTGCTGG
G6pc CTTTCAGCCACATCCGGGGC CCCATTCTGGCCGCTCACAC
doi:10.1371/journal.pone.0011107.t003
Pank1 Knockout Mice
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ultramicratome using a Diatome diamond knife. They were
stained with lead citrate and 8% uranyl acetate. The sections were
imaged on a JEOL 1200EX11 Transmission Electron Microscope
with an AMT XR111 11 megapixel Digital Camera.
Measurements of Fatty Acid Oxidation
The procedure described by Adams et al. [72] was adapted to
measure the rate of [9,10-
3H]palmitic acid oxidation in the liver
homogenates of Pank1 knockout and control mice. Duplicate samples
were used. Briefly, livers from Pank1 knockout and control mice were
excised, rinsed in cold isolation buffer (220 mM mannitol, 70 mM
sucrose, 2 mM Hepes, 0.1 mM EDTA, pH 7.2), blotted dry, pooled
(2–3 per group) and weighed. The livers were homogenized in
isolation buffer to a final concentration of 400 mg of tissue/ml. The
reaction buffer contained 1 mM L-carnitine, 13.1 mM sucrose,
78 mM Tris-HCl, 10.5 mM K2HPO4,3 1 . 5m MK C l ,5m MA T P ,
1m MN A D
+, 850 mM EDTA, 500 mMp a l m i t i ca c i d ,1 . 7mMo f
[9,10-
3H]palmitic acid (60 Ci/mmol) and 100 mg/ml fatty acid-free
BSA, pH 7.4. Ethanol stock solutions of radiolabeled and unlabeled
palmitic acid were added directly to the reaction buffer. Reactions
were started by the addition of 100 ml of homogenate to 250 mlo f
reactionbuffer andincubatedat 37uCfor15 min.The reactionswere
stopped by adding 150 ml of 30% perchloric acid and centrifuged at
20,0006g, 4uC for 2 min to pellet the precipitated proteins. The
supernatants were set aside and the pellets washed with 0.5 ml of
water and centrifuged again. The two supernatants per sample were
then combined and the [
3H]water produced by b-oxidation in each
sample was separated from [9,10-
3H]palmitic acid using the lipid
extraction procedure described by Bligh and Dyer [69]. Aliquots of
the aqueous phases were transferred to scintillation vials and counted.
Quantification of Acyl-Carnitines
Acyl-carnitines were extracted, identified and quantified by
mass spectrometry as described previously [73,74]. Acyl-carnitines
were extracted from 250 mg of liver by freezing the sample in
liquid nitrogen and grinding the sample into a powder. To the
liver powder, 1 ml of 8:2 (v/v) acetonitrile:water was added along
with 70 ml of Labeled Carnitine Standards Set B (Cambridge
Isotope Laboratories, Inc.). The suspension was sonicated six times
for 10 s using the Sonicator 3000 (Misonix). The samples were
centrifuged at 160006g for 5 min and the supernatant was saved.
The supernatant was added to a Bond Elut – PRS column
(Varian) which was activated by washing the column with 3 ml of
methanol and 3 ml 100:3.5 (v/v) methanol:HCl followed by two
3 ml washes of water. The column was again washed twice with
3 ml water and once with 3 ml methanol. Elution from the
column was done three times with 1 ml of 40 mM BaCl2 in 75%
methanol. Elution fractions were pooled together and evaporated
under nitrogen. The residue was resuspended in 3 ml acetonitrile
and transferred to a new tube to be evaporated. To the residue,
200 ml of 4:1 (v/v) 2-propanol:acetylchloride was added and
incubated a 65uC for 15 min. The reaction mix was evaporated
under nitrogen, and 300 ml of acetonitrile was added to resuspend
the sample. This resuspension was used to measure the acyl-
carnitines by taking 70 ml of the sample and adding 30 ml of water.
This dilution was used for direct-infusion ESI-MS technology by
the Hartwell Center for Bioinformatics and Biotechnology, St.
Jude Children’s Research Hospital using a Finnigan
TM TSQH
Quantum (Thermo Electron, San Jose, CA) triple quadrupole
mass spectrometer. The instrument was operated in the positive
ion mode with the following ion source parameters: spray voltage
3500 V, capillary temperature 120uC, capillary offset 35 V, and
tube lens offset was set by infusion of the polytyrosine tuning and
calibration solution (Thermo Electron, San Jose, CA) in electro-
spray mode. Acquisition parameters for propylated acylcarnitines
were: scan range 180–600 m/z, scan time 0.5 s, product mass
85 m/z, collision energy 20 V, peak width Q1 and Q3 0.7
FWHM, and Q2 CID gas 0.5 mTorr. To calculate the amount of
each acyl-carnitine, the peak height for each acyl-carnitine was
compared to the peak height of the appropriate internal standard.
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